Investors should monitor Centene's major support levels at $27 and $17, along with resistance levels near $42 and $74. The company's shares dropped 40% due to lower growth expectations and higher patient illness rates, impacting its 2025 results significantly.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing